Wuhan Thalys Medical Technology
Overview
Thalys Medical Technology Group Corp, formerly Thalys Medical Technology Inc, is a China-based company principally engaged in the provision of intensified distribution business and simple sales business and the research, design, manufacture and distribution of independent in vitro diagnostic products . Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment . The Company mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LevitasBio | Jan 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Wuhan Thalys Medical Technology based?
Wuhan Thalys Medical Technology is headquartered in Wuhan, Hubei, China.
When was Wuhan Thalys Medical Technology founded?
Wuhan Thalys Medical Technology was founded in 2004.
How many portfolio companies does Wuhan Thalys Medical Technology have?
Wuhan Thalys Medical Technology has 1 portfolio company in Caplight's dataset.
What are some companies in Wuhan Thalys Medical Technology's portfolio?
Portfolio companies visible on Caplight include LevitasBio.
What was Wuhan Thalys Medical Technology's most recent investment shown here?
Wuhan Thalys Medical Technology's most recent investment in this portfolio sample was in LevitasBio in 2021.
What sectors does Wuhan Thalys Medical Technology focus on?
Wuhan Thalys Medical Technology focuses on Healthcare & Life Sciences.
What company stages does Wuhan Thalys Medical Technology focus on?
Wuhan Thalys Medical Technology typically invests at the Mid stage.